Impact of coinfection with HIV-1 and GB virus C in patients receiving a ritonavir-boosted HAART regimen: a substudy to the MaxCmin1 trial
Tillmann H, Lundgren J, Dragsted U, Hill A, Vernazza P, Monforte A, Antunes F, Staszewski S, Fox Z, Kaiser T, MaxCmin1 Trial Group. Impact of coinfection with HIV-1 and GB virus C in patients receiving a ritonavir-boosted HAART regimen: a substudy to the MaxCmin1 trial. Journal of acquired immune deficiency syndromes (1999) 2005; 40:378-80.
01.11.2005
Impact of coinfection with HIV-1 and GB virus C in patients receiving a ritonavir-boosted HAART regimen: a substudy to the MaxCmin1 trial
01.11.2005
Journal of acquired immune deficiency syndromes (1999) 2005; 40:378-80
Tillmann Hans L, Lundgren Jens D, Dragsted Ulrik B, Hill Andrew, Vernazza Pietro, Monforte Antonella d'Arminio, Antunes Francesco, Staszewski Schlomo, Fox Zoe, Kaiser Thorsten, MaxCmin1 Trial Group
Weiter